More than 30 published articles have suggested that a protein kinase called MELK is an attractive therapeutic target in human cancer, but three recent reports describe compelling evidence that it is not. These reports highlight the caveats associated with some of the research tools that are commonly used to validate candidate therapeutic targets in cancer research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805407 | PMC |
http://dx.doi.org/10.7554/eLife.32402 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!